Acumyn, which spun-out of Toronto’s University Hospital Network, was started to commercialize the Aqua software platform. Aqua is intended to coordinate, centralize and automate all QA tests that need to be performed in radiotherapy clinics, Elekta said.
“This acquisition is an important step in our Elekta digital strategy. With Aqua as the backbone for all quality assurance measurements in the clinic, we can now integrate machine data acquisition and analysis across the whole department,” Elekta prez & CEO Richard Hausmann said in a prepared statement.
Elekta said it plans to fully integrate the Aqua software across its portfolio and continue to develop QA offerings through the Acumyn team.
“Aqua fills a big gap that radiotherapy departments have today. A linear accelerator and associated devices need to be calibrated and maintained on a regular basis. Aqua provides a software link between all the disparate systems and manages the workload, scheduling and reporting of routine QA tasks,” Elekta portfolio & biz dev senior VP Dee Mathieson said in prepared remarks.
Acumyn’s Aqua supports internationally recognized QA tests and standards, Elekta said, and is intended to supply clinics with limited physics resources to enable the adoption and implementation of advanced treatment techniques.
“The team and I are excited to become part of Elekta and look forward to realizing our development plans for Aqua. We plan to further integrate and automate the incongruous elements of the end-to-end QA process and leverage the wider potential of Aqua across Elekta’s treatment solutions,” Acumyn CEO Ferhan Bulca said in a press release.
Earlier this month, Croton Healthcare subsidiary York Instruments announced plans to buy Elekta’s magnetoencephalography business for an undisclosed amount.